Ventures
Yong Qin Zeng

Yong Qin Zeng

Innovation Lead,
Greater China

Current role

Yong Qin has extensive research experience in both academia and industry, including start-ups. She’s a passionate advocate for open innovation — a collaborative approach to research and development that’s a stark contrast to the siloed mindset that has traditionally dominated industries. At Philips Ventures, she collaborates with new partners to help them identify consumer needs and guide them to solutions. She’s also driven the development of multiple venture projects, which have led to two new business unit creations.

Experience

At Philips, Yong Qin previously led three research departments: wireless communication, LED lighting systems and services, healthcare equipment and medical informatics. She also served on the faculty of Chongqing University. Earlier in her career, she received her BSc and MSc from Chongqing University and was awarded the Sino-British Friendship Scholarship Scheme (SBFSS) to pursue her PhD in Imperial College in the UK.

When I was a child, I wished to become a doctor to help patients, but my parents persuaded me to study electronics. I’m very grateful to work on healthcare innovation, which has made my childhood dream come true.”

Areas of focus

 

  • Artificial intelligence for radiology, cardiology and oncology
  • Mobile monitoring solutions and services
  • Hospital operation optimization

Yong Qin contributed a chapter on open innovation to China's Next Strategic Advantage: From Imitation to Innovation (MIT, 2016).

Cover of China’s Next Strategic Advantage book

Want to become a start-up partner with Philips Ventures?

Contact information

* This field is mandatory

*
*
*
*
*

*
*
*
 
Changing healthcare

Together, we’re changing healthcare

Together, we’re changing healthcare

Philips Ventures champions innovative start-ups with breakthrough solutions.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.